R

ise and shine, everyone. The middle of the week is upon us. Have heart, though. You made it this far, so why not hang on for another couple of days, yes? After all, consider the alternatives. And what better way to make the time fly than to keep busy. So grab that cup of stimulation — our flavor today boasts the aroma of blueberries — and get started. Meanwhile, do keep us in mind if you hear anything interesting. We love secrets. Have a smashing day …

Food and Drug Administration Commissioner Scott Gottlieb, who is considered a potential successor to recently departed U.S. Health and Human Services Secretary Tom Price, tells Reuters that he can best serve the Trump administration in his current role. “I feel like I want to continue to follow through on the policies we’ve put out and it’s where I think I can be most effective,” he says.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

  • Since you cannot ‘inspect quality in,’ don’t let inspectors become too familiar with your medical device plant. Rotate those who come – so there will be less chance of recalls. Yes, we wouldn’t want FDA personnel to be come expert in the processes of a site. “Good grief, Charley Brown!”

Sign up for our Biotech newsletter — The Readout

Your daily guide to what’s new in biotech.